Keith J. Johnson

12.5k citations
164 papers · 10.6k · 3 hit papers · h-index 43

Impact in

Papers in

    • Genetic Neurodegenerative Diseases 55
    • Neuroscience and Neuropharmacology Research 8
    • Mitochondrial Function and Pathology 23
    • Ion channel regulation and function 10
    • Fungal and yeast genetics research 8
    • Ubiquitin and proteasome pathways 7

Keith J. Johnson

161 papers receiving 10.1k citations

Keith J. Johnson's Hit Papers

Trial of Solanezumab in Preclinical Alzheimer’s Disease 2023 · 267 citations
2670+11+23Years since publication50010001.5k2.0k

Peers

Keith J. Johnson
Comparison fields: 5 of 158
  • Cellular and Molecular Neuroscience 4.8k
  • Neurology 1.6k
  • Molecular Biology 5.7k
  • Immunology 1.2k
  • Aging 99
Replace Dennis E. Bulman with:
Dennis E. Bulman Canada
Nicholas W. Gale United States
Roberto Bruzzone France
Daniel Caput France
Melanie Bahlo Australia
Mustafa Abdalla M Salih Saudi Arabia
Martin M. Y. Lammens Netherlands
Robert Day Canada
Robin J. Leach United States
Noriko Miyake Japan
Keith J. Johnson relative to Dennis E. Bulman Canada Dennis E. Bulman's profile →
Citations per field
00.5×1.5×2×2.3×
Dennis E. Bulman · 1×
Citations per year

Countries citing papers authored by Keith J. Johnson

Since Specialization
Citations

This map shows the geographic impact of Keith J. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith J. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith J. Johnson more than expected).

Fields of papers citing papers by Keith J. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith J. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith J. Johnson. The network helps show where Keith J. Johnson may publish in the future.

Co-authors

The 25 scholars most cited alongside Keith J. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Keith J. Johnson Line = papers co-authored together Keith J. Johnson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 164 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member
Hit paper breakdown →
19922371
2
Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
Hit paper breakdown →
19911757
3 1992530
4 1992426
5 1990323
6
Trial of Solanezumab in Preclinical Alzheimer’s Disease
Hit paper breakdown →
2023267
7 1994240
8
Myotonic dystrophy: size- and sex-dependent dynamics of CTG meiotic instability, and somatic mosaicism.
1993213
9 1993186
10 2005178
11 2004174
12 1993170
13 1991168
14 1995154
15 2012132
16
Mechanisms of inactivation of E-cadherin in breast cancer cell lines.
1998127
17 1993127
18
Meiotic models to explain classical linkage, pseudolinkage, and chromosome pairing in tetraploid derivative salmonid genomes.
1983107
19 1992105
20 199285

About Keith J. Johnson

Keith J. Johnson is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology, Genetics, Neurology and Psychiatry and Mental health, having authored 164 papers that have together received 10.6k indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (55 papers), Mitochondrial Function and Pathology (23 papers), Ion channel regulation and function (10 papers), Parkinson's Disease Mechanisms and Treatments (9 papers), Neuroscience and Neuropharmacology Research (8 papers), Fungal and yeast genetics research (8 papers), Ubiquitin and proteasome pathways (7 papers) and Dementia and Cognitive Impairment Research (6 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (4.8k citations), Neurology (1.6k citations), Molecular Biology (5.7k citations), Immunology (1.2k citations) and Aging (99 citations). Keith J. Johnson has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include René de Waal Malefyt, Rob A. KASTELEIN, Hergen Spits, John B.A.G. Haanen, Carl Gustav Figdor, Maria Grazia Roncarolo, Hans Yssel, J E de Vries, Peggy Shelbourne and Jessica L. Buxton. Their work appears in journals such as Genomics, Human Molecular Genetics, Journal of Medical Genetics, Nucleic Acids Research and Alzheimer s & Dementia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact